6 results match your criteria: "New England Deaconness Hospital[Affiliation]"
Transplant Proc
April 1996
Sandoz Center for Immunobiology, New England Deaconness Hospital, Boston, Massachusetts 02215, USA.
Transplant Proc
April 1996
Sandoz Center for Immunobiology, New England Deaconness Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA.
Transplant Proc
April 1996
Sandoz Center for Immunobiology, New England Deaconness Hospital, Harvard Medical School, Boston, Mass. 02215, USA.
Transplant Proc
April 1996
Division of Organ Transplantation, New England Deaconness Hospital, Harvard Medical School, Boston, Massachusetts, USA.
J Occup Med
June 1994
Department of Medicine, New England Deaconness Hospital, Boston, Massachusetts.
We present the case of a worker who was accidentally exposed (inhalational and dermal routes) to the chemicals dimethylacetamide and ethylenediamine for 90 minutes in a confined space. Clinical effects included delirium, hallucinations, skin burns, cellulitis, bilateral conjunctivitis, hepatitis, secondary coagulopathy, rhabdomyolysis, and a grade 2 esophagitis. Urinary monomethylacetamide levels 6 days after the exposure were 61 ppm.
View Article and Find Full Text PDFTransfus Sci
August 1992
Blood Bank and Tissue Typing Laboratory, Department of Pathology and Laboratory Medicine, New England Deaconness Hospital, and Department of Medicine, Harvard Medical School, Boston, MA 02115.
For at least two decades the light-spin/hard-spin (LS/HS) method for preparation of platelet concentrates (PC) has been the standard of platelet support. With concern over the detrimental effects of platelet activation during component preparation and with increased recognition of the adverse consequences resulting from residual donor leukocytes in PC, new approaches to the production of PC have begun. This review addresses two aspects of the traditional LS/HS method of platelet preparation: platelet activation and residual leukocyte content.
View Article and Find Full Text PDF